Overview

Dimethyl Fumarate for Obstructive Sleep Apnea

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

The overall purpose of this study is to determine whether the oral medication dimethyl fumarate is an effective treatment for obstructive sleep apnea in patients who are unable, unwilling, or uneager to use positive airway pressure therapy.

Phase:

Phase 2

Details

Lead Sponsor:

University of Michigan

Treatments:

Dimethyl Fumarate